These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2993145)
1. Acetaminophen hepatotoxicity and targeted rescue: a model for specific chemotherapy of hepatocellular carcinoma. Wu GY; Wu CH; Rubin MI Hepatology; 1985; 5(5):709-13. PubMed ID: 2993145 [TBL] [Abstract][Full Text] [Related]
2. Model for specific rescue of normal hepatocytes during methotrexate treatment of hepatic malignancy. Wu GY; Wu CH; Stockert RJ Proc Natl Acad Sci U S A; 1983 May; 80(10):3078-80. PubMed ID: 6190170 [TBL] [Abstract][Full Text] [Related]
3. Targeted protection of hepatocytes from galactosamine toxicity in vivo. Keegan-Rogers V; Wu GY Cancer Chemother Pharmacol; 1990; 26(2):93-6. PubMed ID: 1693313 [TBL] [Abstract][Full Text] [Related]
4. Targeted inhibition of transferrin-mediated iron uptake in Hep G2 hepatoma cells. Wu GY; Wu CH J Biol Chem; 1986 Dec; 261(36):16834-7. PubMed ID: 3023366 [TBL] [Abstract][Full Text] [Related]
5. Endocytosis and function of the hepatic asialoglycoprotein receptor. Weigel PH Subcell Biochem; 1993; 19():125-61. PubMed ID: 8385817 [No Abstract] [Full Text] [Related]
6. Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes. Cawley DB; Simpson DL; Herschman HR Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3383-7. PubMed ID: 6167984 [TBL] [Abstract][Full Text] [Related]
12. Ligand-induced modulation of the hepatic receptor for asialoglycoproteins in the human hepatoblastoma cell line, Hep G2. Steer CJ; Weiss P; Huber BE; Wirth PJ; Thorgeirsson SS; Ashwell G J Biol Chem; 1987 Dec; 262(36):17524-9. PubMed ID: 2826424 [TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated transport of oligodeoxynucleotides into hepatic cells. Reinis M; Damková M; Korec E J Virol Methods; 1993 Apr; 42(1):99-105. PubMed ID: 7686560 [TBL] [Abstract][Full Text] [Related]
14. The pathway of the asialoglycoprotein-ligand during receptor-mediated endocytosis: a morphological study with colloidal gold/ligand in the human hepatoma cell line, Hep G2. Geuze HJ; Slot JW; Strous GJ; Schwartz AL Eur J Cell Biol; 1983 Nov; 32(1):38-44. PubMed ID: 6321187 [TBL] [Abstract][Full Text] [Related]
15. Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. Wu GY; Wu CH Biochemistry; 1988 Feb; 27(3):887-92. PubMed ID: 2835080 [TBL] [Abstract][Full Text] [Related]
16. Hepatic recognition and catabolism of serum glycoproteins. Ashwell G; Steer CJ JAMA; 1981 Nov; 246(20):2358-64. PubMed ID: 6271991 [No Abstract] [Full Text] [Related]
17. Receptor-mediated protection of normal hepatocytes during chemotherapy for hepatocellular carcinoma. Keegan-Rogers V; Wu CH; Wu GY Targeted Diagn Ther; 1991; 4():105-25. PubMed ID: 1665717 [No Abstract] [Full Text] [Related]
18. Targeted antagonism of galactosamine toxicity in normal rat hepatocytes in vitro. Wu GY; Keegan-Rogers V; Franklin S; Midford S; Wu CH J Biol Chem; 1988 Apr; 263(10):4719-23. PubMed ID: 3350810 [TBL] [Abstract][Full Text] [Related]
19. Galactosylated histone-mediated gene transfer and expression. Chen J; Stickles RJ; Daichendt KA Hum Gene Ther; 1994 Apr; 5(4):429-35. PubMed ID: 8049301 [TBL] [Abstract][Full Text] [Related]
20. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Ng LT; Chiang LC; Lin YT; Lin CC Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]